Volume 27, Number 2—February 2021
CME ACTIVITY - Synopsis
Zika Virus–Associated Birth Defects, Costa Rica, 2016–2018
Figure 2

Figure 2. Reported cases and classification of suspected cases of ZBD according to protocol, Costa Rica, March 2016–March 2018. rRT-PCR, real-time reverse transcription PCR; STORCH, syphilis, toxoplasmosis, rubella, cytomegalovirus, and hepatitis B (note that Costa Rica does not include hepatitis B in its standard evaluations); ZBD, Zika virus–associated birth defects.
Page created: December 07, 2020
Page updated: January 21, 2021
Page reviewed: January 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.